Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population

Psychiatric Genetics

Volumn 22, Issue 3, 2012, Pages 141-145

  Ambrose Lanci, Lisa M ^a   Vaswani, Meera ^a,b   Clarke, Toni Kim ^a   Zeng, Angela ^a   Lohoff, Falk W ^a   Ferraro, Thomas N ^a   Berrettini, Wade H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AARB2; case control association study; cocaine dependence; opioid dependence

Indexed keywords

BETA ARRESTIN 2;

ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARRESTINS; COCAINE-RELATED DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860312812     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283539528     Document Type: Article

References (37)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview:analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
2. Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ (2004). Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 9:547-549.
3. Becker A, Grecksch G, Kraus J, Loh HH, Schroeder H, Hollt V (2002). Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 365:296-302. (Pubitemid 34280369)
4. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999). Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498.
5. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000). Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723. (Pubitemid 32015987)
6. Bohn LM, Lefkowitz RJ, Caron MG (2002). Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500. (Pubitemid 35416886)
7. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG (2003). Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci23:10265-10273. (Pubitemid 37444603)
8. Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP (2010). Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res 178:295-298.
9. Crowley JJ, Oslin DW, Patkar AA, Gottheil E, DeMaria PA Jr., O'Brien CP, et al. (2003). A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 13:169-173. (Pubitemid 37082977)
10. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004). Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144. (Pubitemid 39050399)
11. Gelernter J, Panhuysen C, Wilcox M, Hesselbrock V, Rounsaville B, Poling J, et al. (2006). Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet 78:759-769.
12. Haberstock-Debic H, Kim KA, Yu YJ, von Zastrow M (2005). Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons. J Neurosci 25:7847-7857. (Pubitemid 41208657)
13. Hall FS, Goeb M, Li XF, Sora I, Uhl GR (2004). mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. Brain Res Mol Brain Res 121:123-130. (Pubitemid 38224176)
14. Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, et al. (2000). Sequence variability and candidate gene analysis in complex disease:association of mu opioid receptor gene variation with substance depen-dence. Hum Mol Genet 9:2895-2908.
15. Hummel M, Schroeder J, Liu-Chen LY, Cowan A, Unterwald EM (2006). An antisense oligodeoxynucleotide to the mu opioid receptor attenuates cocaine-induced behavioral sensitization and reward in mice. Neuroscience 142:481-491. (Pubitemid 44415328)
16. Ikeda M, Ozaki N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. (2007). Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav 6:107-112. (Pubitemid 46090337)
17. Karkowski LM, Prescott CA, Kendler KS (2000). Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. Am J Med Genet 96:665-670.
18. Kendler KS, Prescott CA (1998). Cocaine use, abuse and dependence in a population-based sample of female twins. Br J Psychiatry 173:345-350. (Pubitemid 28454823)
19. Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000). Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry57:261-269. (Pubitemid 30140435)
20. Kendler KS, Jacobson KC, Prescott CA, Neale MC (2003). Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160:687-695. (Pubitemid 41079601)
21. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA (2005). Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57:1-26. (Pubitemid 40283968)
22. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J, et al. (2008). Genetic susceptibility to heroin addiction:a candidate gene association study. Genes Brain Behav 7:720-729.
23. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823.
24. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, et al. (1998). Familial transmission of substance use disorders. Arch Gen Psychiatry 55:973-979. (Pubitemid 28506838)
25. Milligan G (2005). Opioid receptors and their interacting proteins. Neuromole-cular Med 7:51-59.
26. Oneda B, Crettol S, Bochud M, Besson J, Croquette-Krokar M, Hammig R, et al. (2011). β-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics J 11:258-266.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. (2007). PLINK:a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575. (Pubitemid 47330214)
28. Saxon AJ, Oreskovich MR, Brkanac Z (2005). Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry 13:218-232. (Pubitemid 41437573)
29. Smith RJ, Doyle GA, Han AM, Crowley JJ, Oslin DW, Patkar AA, et al. (2005). Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. Am J Med Genet B Neuropsychiatr Genet 133B:105-109. (Pubitemid 40175626)
30. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, et al. (1997). Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549. (Pubitemid 27087888)
31. Sun D, Ma JZ, Payne TJ, Li MD (2008). Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. Mol Psychiatry 13:398-406. (Pubitemid 351399815)
32. Szeto CY, Tang NL, Lee DT, Stadlin A (2001). Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 12:1103-1106. (Pubitemid 32374725)
33. Tan EC, Tan CH, Karupathivan U, Yap EP (2003). Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14:569-572. (Pubitemid 36528992)
34. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. (1998). Co-occurrence of abuse of different drugs in men:the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry55:967-972. (Pubitemid 28506837)
35. Yuferov V, Levran O, Proudnikov D, Nielsen DA, Kreek MJ (2010). Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci 1187:184-207.
36. Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, et al. (2006). Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15:807-819. (Pubitemid 43338224)
37. Zhang X, He JQ, Ding L, Pare PD, Sandford AJ (2007). Promoter polymorph-ism and expression of beta-arrestin 2 in neutrophils. Clin Chim Acta 385:79-80. (Pubitemid 47374673)